Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1893 1
1918 2
1921 1
1922 1
1923 1
1932 2
1934 1
1935 1
1937 2
1938 2
1939 4
1942 1
1943 2
1944 1
1946 2
1949 3
1951 5
1952 3
1953 2
1955 2
1956 3
1957 9
1958 6
1959 3
1960 3
1961 2
1962 2
1963 3
1965 2
1966 1
1967 3
1969 1
1970 1
1971 3
1972 3
1973 1
1974 3
1975 1
1976 9
1977 2
1978 2
1979 1
1980 3
1981 2
1982 5
1983 1
1984 3
1985 1
1986 5
1987 5
1988 4
1989 5
1990 6
1991 2
1992 3
1993 5
1994 4
1996 1
1997 3
1998 1
1999 1
2000 8
2001 5
2002 7
2003 7
2004 6
2005 3
2006 4
2007 3
2008 9
2009 11
2010 9
2011 13
2012 8
2013 12
2014 13
2015 4
2016 8
2017 9
2018 4
2019 7
2020 6
Text availability
Article attribute
Article type
Publication date

Search Results

307 results
Results by year
Filters applied: . Clear all
Page 1
Candidate biomarkers of PARP inhibitor sensitivity in ovarian cancer beyond the BRCA genes.
Hodgson DR, Dougherty BA, Lai Z, Fielding A, Grinsted L, Spencer S, O'Connor MJ, Ho TW, Robertson JD, Lanchbury JS, Timms KM, Gutin A, Orr M, Jones H, Gilks B, Womack C, Gourley C, Ledermann J, Barrett JC. Hodgson DR, et al. Among authors: robertson jd. Br J Cancer. 2018 Nov;119(11):1401-1409. doi: 10.1038/s41416-018-0274-8. Epub 2018 Oct 24. Br J Cancer. 2018. PMID: 30353044 Free PMC article. Clinical Trial.
Efficacy and safety of olaparib monotherapy in germline BRCA1/2 mutation carriers with advanced ovarian cancer and three or more lines of prior therapy.
Domchek SM, Aghajanian C, Shapira-Frommer R, Schmutzler RK, Audeh MW, Friedlander M, Balmaña J, Mitchell G, Fried G, Stemmer SM, Hubert A, Rosengarten O, Loman N, Robertson JD, Mann H, Kaufman B. Domchek SM, et al. Among authors: robertson jd. Gynecol Oncol. 2016 Feb;140(2):199-203. doi: 10.1016/j.ygyno.2015.12.020. Epub 2015 Dec 23. Gynecol Oncol. 2016. PMID: 26723501 Free PMC article. Clinical Trial.
Long-Term Responders on Olaparib Maintenance in High-Grade Serous Ovarian Cancer: Clinical and Molecular Characterization.
Lheureux S, Lai Z, Dougherty BA, Runswick S, Hodgson DR, Timms KM, Lanchbury JS, Kaye S, Gourley C, Bowtell D, Kohn EC, Scott C, Matulonis U, Panzarella T, Karakasis K, Burnier JV, Gilks CB, O'Connor MJ, Robertson JD, Ledermann J, Barrett JC, Ho TW, Oza AM. Lheureux S, et al. Among authors: robertson jd. Clin Cancer Res. 2017 Aug 1;23(15):4086-4094. doi: 10.1158/1078-0432.CCR-16-2615. Epub 2017 Feb 21. Clin Cancer Res. 2017. PMID: 28223274 Free article. Clinical Trial.
Biological and clinical evidence for somatic mutations in BRCA1 and BRCA2 as predictive markers for olaparib response in high-grade serous ovarian cancers in the maintenance setting.
Dougherty BA, Lai Z, Hodgson DR, Orr MCM, Hawryluk M, Sun J, Yelensky R, Spencer SK, Robertson JD, Ho TW, Fielding A, Ledermann JA, Barrett JC. Dougherty BA, et al. Among authors: robertson jd. Oncotarget. 2017 Jul 4;8(27):43653-43661. doi: 10.18632/oncotarget.17613. Oncotarget. 2017. PMID: 28525389 Free PMC article.
Olaparib monotherapy in patients with advanced relapsed ovarian cancer and a germline BRCA1/2 mutation: a multistudy analysis of response rates and safety.
Matulonis UA, Penson RT, Domchek SM, Kaufman B, Shapira-Frommer R, Audeh MW, Kaye S, Molife LR, Gelmon KA, Robertson JD, Mann H, Ho TW, Coleman RL. Matulonis UA, et al. Among authors: robertson jd. Ann Oncol. 2016 Jun;27(6):1013-1019. doi: 10.1093/annonc/mdw133. Epub 2016 Mar 8. Ann Oncol. 2016. PMID: 26961146 Free article.
Gold Nanoparticle Transforms Activated Cancer-Associated Fibroblasts to Quiescence.
Hossen MN, Rao G, Dey A, Robertson JD, Bhattacharya R, Mukherjee P. Hossen MN, et al. Among authors: robertson jd. ACS Appl Mater Interfaces. 2019 Jul 24;11(29):26060-26068. doi: 10.1021/acsami.9b03313. Epub 2019 Jul 11. ACS Appl Mater Interfaces. 2019. PMID: 31117437 Free PMC article.
Precocious neuronal differentiation and disrupted oxygen responses in Kabuki syndrome.
Carosso GA, Boukas L, Augustin JJ, Nguyen HN, Winer BL, Cannon GH, Robertson JD, Zhang L, Hansen KD, Goff LA, Bjornsson HT. Carosso GA, et al. Among authors: robertson jd. JCI Insight. 2019 Oct 17;4(20):e129375. doi: 10.1172/jci.insight.129375. JCI Insight. 2019. PMID: 31465303 Free PMC article.
Demonstration of a novel Xp22.2 microdeletion as the cause of familial extreme skewing of X-inactivation utilizing case-parent trio SNP microarray analysis.
Mason JA, Aung HT, Nandini A, Woods RG, Fairbairn DJ, Rowell JA, Young D, Susman RD, Brown SA, Hyland VJ, Robertson JD. Mason JA, et al. Among authors: robertson jd. Mol Genet Genomic Med. 2018 May;6(3):357-369. doi: 10.1002/mgg3.378. Epub 2018 Feb 28. Mol Genet Genomic Med. 2018. PMID: 29490426 Free PMC article.
Pediatric transplantation: preventing thrombosis.
Robertson JD. Robertson JD. J Thromb Haemost. 2015 Jun;13 Suppl 1:S351-61. doi: 10.1111/jth.12968. J Thromb Haemost. 2015. PMID: 26149047 Free article. Review.
Purification of Nanoparticles by Size and Shape.
Robertson JD, Rizzello L, Avila-Olias M, Gaitzsch J, Contini C, Magoń MS, Renshaw SA, Battaglia G. Robertson JD, et al. Sci Rep. 2016 Jun 8;6:27494. doi: 10.1038/srep27494. Sci Rep. 2016. PMID: 27271538 Free PMC article.
307 results
Jump to page
Feedback